Roche, the Swiss giant, has developed a drug to treat an aggressive form of breast cancer. The drug has been found to extend patients' lives by almost 16 months, said researchers on Sunday. Patients who took the new Perjeta drug in combination with chemotherapy and Roche's older anti-cancer drug Herceptin lived a median of 56.5 months, compared to 40.8 months for people in the trial who weren't on Perjeta, Roche said in a statement. "Adding Perjeta to ...
Read More
You have just read an article categorized health
titled Breast Cancer Drug from Roche 'Helps Patients Live Longer'.
Written by:
editor -
Monday, September 29, 2014
There are currently no comments for "Breast Cancer Drug from Roche 'Helps Patients Live Longer'"
Post a Comment